Linguistic spin in randomized controlled trials about age-related macular degeneration

Publication date

2022-10-31

Authors

Veldhuis, Nienke
Nuijts, Myrthe A.
Isphording, Luka
Lee-Kong, Felicia V.Y.L.
Imhof, SaskiaISNI 0000000391274981
Stegeman, IngeORCID 0000-0001-5154-7178ISNI 0000000423219064

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Objective: To evaluate the prevalence, type and extent of linguistic spin in randomized controlled trials (RCTs) exploring interventions in patients with age-related macular degeneration (AMD), as well as to investigate whether study variables were correlated with linguistic spin. Study design and setting: PubMed was searched from 2011 to 2020 to identify RCTs including patients with AMD. Two authors independently assessed a total of 96 RCTs. Linear regression analyses were performed to investigate whether linguistic spin was correlated with predefined study variables. Results: Linguistic spin was found in 61 of 96 abstracts (63.5%) and in 90 of 96 main texts (93.8%). Use of words pointing out the beneficial effect of a treatment and the use of ‘(statistically) significant/significance' without reporting a P-value or a 95% confidence interval (CI) were the most frequently identified categories of linguistic spin. Sample size was significantly correlated with the total linguistic spin score (95% CI 0.38–5.23, P = 0.02). Conclusion: A high prevalence and extent of linguistic spin in RCTs about AMD was found. We highlighted the importance of objective reporting and awareness of linguistic spin among ophthalmologists and other readers.

Keywords

age-related macular degeneration (AMD), linguistic spin, ophthalmology, overinterpretation, randomized controlled trial, Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Health(social science)

Citation

Veldhuis, N, Nuijts, M A, Isphording, L, Lee-Kong, F V Y L, Imhof, S M & Stegeman, I 2022, 'Linguistic spin in randomized controlled trials about age-related macular degeneration', Frontiers in Epidemiology, vol. 2, 961996. https://doi.org/10.3389/fepid.2022.961996